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Summary 
The INK4a (MTS7, CDKNS) gene encodes an inhibitor 
(~16’~~~~) of the cyclin D-dependent kinases CDK4 and 
CDK6 that blocks them from phosphorylating the reti- 
noblastoma protein (pRB) and prevents exit from the 
Gl phase of the cell cycle. Deletions and mutations 
involving INK4a occur frequently in cancers, implying 
that p16’NK4a, like pRB, suppresses tumor formation. 
An unrelated protein (plSARF) arises in major part from 
an alternative reading frame of the mouse INK4a gene, 
and its ectopic expression in the nucleus of rodent 
fibroblasts induces Gl and G2 phase arrest. Economi- 
cal reutilization of coding sequences in this manner is 
practically without precedent in mammalian genomes, 
and the unitary inheritance of p161NK4” and plSARF may 
underlie their dual requirement in cell cycle control. 
Introduction 
Tandemly linked /NK#a (for inhibitor of CDK4; also known 
as MTS7, for multiple tumor suppressor, or CDKN2, for 
cyclin-dependent kinase N2) and INK4b (MTS2) genes on 
the short arm of human chromosome 9 encode distinct 
16 kDa and 15 kDa inhibitors (pl 6’NK4a and pl 5’NK4b, respec- 
tively) of the Gl cyclin D-dependent kinases CDK4 and 
CDK6 (Serrano et al., 1993; Hannon and Beach, 1994). 
Homozygous codeletion of INK4a and INK4b, hemizygous 
deletions of INK4a together with point mutations within the 
remaining allele, and de novo methylation of a CpG island 
extending into INK4a exon 1 are commonly observed in 
human cancers, suggesting that p161NK4”, and perhaps 
pl 51NK4b, function as tumor suppressors (Hunter and Pines, 
1994; Kamb et al., 1994a; Nobori et al., 1994; Merlo et 
al., 1995; Sheaff and Roberts, 1995). By contrast, INK4 
genes encoding ~18’~~~ and ~19’~~~~ map to other human 
chromosomes (Guan et al., 1994; Chan et al., 1995; Hirai 
et al., 1995; Okuda et al., 1995) and have not been linked 
to tumor formation, arguing that different INK4 proteins 
are not strictly redundant. 
A critical substrate of cyclin D-dependent kinases is 
the retinoblastoma protein (pRB) (Hunter and Pines, 1994; 
Sherr, 1994), whose phosphorylation late in Gl phase en- 
ables Gl exit (Weinberg, 1995). In accord with the idea 
that INK4 proteins can act to limit the phosphorylation of 
pRB by cyclin D-dependent kinases, ectopic overexpres- 
sion of various INK4 proteins in proliferating cells can in- 
hibit cyclin D-dependent kinases in vivo (Hirai et al., 1995; 
Quelle et al., 1995), induce Gl arrest (Guan et al., 1994; 
Hirai et al., 1995; Koh et al., 1995; Lukas et al., 1995; 
Medema et al., 1995; Quelle et al., 1995), and revert cell 
transformation in normal diploid fibroblasts by ras and 
c-my& but not by ras and adenovirus ElA (Serrano et al., 
1995). Naturally occurring pl6 mutants that lack CDK4- 
inhibitory activity are without effect in these assays (Koh 
et al., 1995; Lukas et al., 1995; Ranade et al., 1995), and 
all INK4 proteins so far tested (~16, ~18, and p19) fail to 
inhibit Gl progression in cells lacking functional pRB 
(Guan et al., 1994; Koh et al., 1995; Lukas et al., 1995; 
Medema et al., 1995). Moreover, inactivation of ~18’~~~~ 
and pRB in tumor cells appears to be mutually exclusive 
(Bates et al., 1994; Lukas et al., 1994; Okamoto et al., 
1994; Otterson et al., 1994; Tam et al., 1994) implying 
that both proteins (as well as cyclin D-dependent kinases) 
function in a single regulatory pathway(Sherr and Roberts, 
1995). 
The human INK4a gene yields two transcripts derived 
from alternative first exons, Ela and E18, each of which 
is joined through the identical splice acceptor site to se- 
quences in exon 2 (Mao et al., 1995; Stone et al., 1995). 
The a and 8 transcripts originating from Ela and E18, 
respectively, are virtually identical in length and have been 
separately identified by reverse transcription and polymer- 
ase chain reactions (RT-PCR) using mRNA templates 
from a variety of human tissues. The a transcript encodes 
~16 ‘NK4a, whereas the 8 transcript contains a 5’ AUG that 
if utilized would initiate translation of an entirely distinct 
polypeptide that incorporates exon 2 coding sequences 
in an alternative reading frame (Figure 1); therefore we 
have designated this polypeptide pl SAW. This dual utili- 
zation of coding sequences is unique in mammals, and 
others presumed that the 8 transcripts would be unlikely 
to encode a protein (Mao et al., 1995; Stone et al., 1.995). 
We have now cloned the mouse INK4a 8 cDNA and show 
that it encodes a naturally expressed polypeptide that is 
entirely different in its amino acid sequence from ~16’~~~~. 
Strikingly, plSARF, like p161NK4”, is able to induce growth 
arrest in mammalian fibroblasts. These findings raise 
questions about the role of the INK4a gene in tumor sup- 
pression and cell cycle control. 
Results and Discussion 
We cloned cDNAs homologous to human INK4a a and 8 
transcripts from a mouse erythroleukemia (MEL) cell li- 
brary and confirmed by Southern blotting that sequences 
from the 1 a and 18 exons hybridized to distinct genomic 
DNA fragments (data not shown). The mouse 8 mRNA 
contains an AUG codon at nucleotides 43-45 flanked by 
Kozak consensus sequences, and translation from this 
initiator would yield a polypeptide of 169 amino acids, mo- 
lecular mass 19,349 daltons (p1gAR9 (Figure 2). Splicing 
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Figure 1. Architecture of the INK4a Gene 
Transcription of a and 6 mRNAs encoding p16’NK~ and plSARF, respec- 
tively, is initiated at two promoters (Stone et al., 1995; Mao et al., 1995). 
Exon 1 a and 18 products are spliced to the same exon 2 acceptor to 
generate a and 8 mRNAs of similar lengths but using alternative read- 
ing frames for translation. Mouse plSARF and ~16’~~~~ are each longer 
than their human cognates, and, like human p161NK4”, the mouse 
~16’~~~~ distal C-terminal amino acids are encoded by a third exon 
(Quelle et al., 1995). Protein coding sequences are depicted by closed 
(pi 61NK47 or hatched (~19~s’) bars, and noncoding sequences by open 
bars. 
of exon 18 to exon 2 of the INK4a gene occurs at the same 
acceptor site as that used by exon 1 a but changes the exon 
2 reading frame to generate a novel protein containing 105 
exon 2-derived residues. The mouse and human 18 exons 
are conserved in length, except for one additional arginine 
Figure 2. Translated Nucleotide Sequence of Mouse INK4a 8 cDNA 
Sequences from exon 18 (nucleotides l-232) are spliced to exon 2 
to create an open reading frame capable of encoding a novel 169 
amino acid protein (~19~~9 terminating at nucleotides 550-552 (under- 
lined TAG). Nucleotides 436-438 (double-underlined CCA) specify a 
TGAterminationcodon in the human /NK4agene(Serranoetal., 1993) 
thereby generating a truncated ARF protein. Unrelated sequences 
from exon 1 c (data not shown) are spliced to the same exon 2 acceptor 
site to open another reading frame that encodes ~16’~~“. Exon 2- 
coded p161NK4” amino acid sequences are shown below those of pi gnnr. 
The C-terminus of mouse pl 61NK”’ IS 20 residues longer than the human 
polypeptide (Quelle et al., 1995) whose last four amino acids are en- 
coded by a third exon (Kamb et al., 1994a). The locations of the primers 
used to cause specific amplification of 8 transcripts by RT-PCR (see 
Figure 3) are underlined. 
codon in the human 8 mRNA located just 5’ of the splice 
donor site. However, the human ARF protein is predicted 
to be 132 amino acids long, owing to a TGA terminator 
in place of CCA at nucleotides 436-438 (underlined in 
Figure 2). Mouse and human ARF polypeptides are 45% 
identical through their exon 18 segments and 50% identi- 
cal overall. By comparison, mouse and human INK4a exon 
1 a segments are 72% identical, and the pl 6rNK@ proteins 
share 65% identity overall. The mouse ARF protein is 
highly basic (22% arginine) and is unrelated to proteins 
in searchable databases. Exon 2 of the INK46 (~15) gene 
contains a cognate second open reading frame capable 
of encoding 59 amino acids if initiated by an alternate 
first exon analogous to El8 in INK4a. Other INK4 family 
members appear to lack this capability. 
plSARF Is Expressed in Mouse Cells 
In a survey of mouse tissues and cell lines, a and b mRNAs 
(each - 1 kb) were detected by Northern blotting with exon 
1 a and 18 probes (data not shown) and, in agreement, by 
RT-PCR using exon 1 a and 18 primers (Figure 3). Specific 
amplification of 8 transcripts and hybridization of the prod- 
ucts with exon 18 (Figure 3A) and exon 2 (Figure 3B) 
probes revealed their ubiquitous expression in various or- 
gans. The signal was particularly high with mRNA tem- 
plates from MEL cells from which 8 cDNAs were preferen- 
f3 transcripts Elfi probe 
8 transcripts ExonP probe 
c transcripts Ela probe 
a transcripts ExonP probe 
Figure 3. INK4a c. and 8 mRNA Transcripts in Mouse Tissues 
Equivalent quantities of RNA from the indicated tissues were amplified 
in parallel by RT-PCR using 5’ primers specific for a or 8 transcripts 
and a common 3’ primer (see Figure 1). Products from 8 (A and B) 
and a (C and D) RT templates were hybridized with specific exon 18 
(A), exon la (C), or exon 2 probes (B and D). Autoradiographic expo- 
sure times were 2 hr. 
INK&! Alternative Reading Frame (ARF) Protein 
995 
tially cloned (see Experimental Procedures). With the 
same templates, a mRNAs encoding pl 61NK4= were ampli- 
fied to high levels from only few tissues (Quelle et al., 
1995), and their more restricted patterns of expression 
helped confirm the specificity of the PCR primers (Figures 
3C and 3D). Amplified a transcripts generated no signal 
after hybridization with the exon 18 probe and vice versa 
(negative data not shown), and no products were obtained 
without mRNA templates (Figure 3). 8 transcripts were 
detected in BALB 3T3 fibroblasts, CTLL-2 and RL-12 T 
cells, and NFSl12 B cells, but were absent from NIH 3T3 
fibroblasts and BAC1.2F5 macrophages, both of which 
have sustained deletions of the INK4a locus (data not 
shown). 
An antiserum directed to the unique C-terminal amino 
acid sequences encoded by the 8 mRNA precipitated a 
protein with an apparent molecular mass of about 22 kDa 
(~19~~‘) after transcription and translation of the 8 cDNA 
in vitro (Figure 4A, lane 8). We have no evidence that 
pl9ARF undergoes posttranslational modification(s) in vivo 
that detectably alter its mobility on denaturing gels (see 
below), so the apparent disparity between the masses of 
the predicted and translated proteins likely reflects the 
unusual amino acid composition of plSARF (see above). 
An antiserum to the C-terminus of mouse pl 6’NK4adetected 
the cognate protein (lane 6) but did not cross-react with 
plSARF (lane 9). When the pl9 N-terminus was tagged with 
a hemagglutinin (HA) epitope, its mobility was slightly re- 
tarded (lane 2), and expression of the protein could be 
demonstrated with anti-HA serum (e.g., see Figure 5 
below). 
By use of sequential immunoprecipitation and immu- 
noblotting, pl SARF was readily detected in lysates of mouse 
MEL cells (Figure 48, lane 7). About 8- to lo-fold lower 
levels of the protein were observed in BALB 3T3 fibroblasts 
(Figure 48, lane 6). Two p53-negative BALB 3T3 sub- 
clones (10-l and 10-3) as well as a derivative cell line 
stably transfected with MDMP, synthesized considerably 
more plSARF (Figure 4B, lanes 3-5), approximating the 
level seen in p53negative MEL cells. Northern blotting 
(data not shown) revealed a close correlation between the 
levels of 8 mRNA and plSARF protein in these cells. 
Whether 8 mRNA expression is regulated by p53 or, con- 
versely, whether loss of ~53 function might be favored in 
cultured cells expressing high levels of plSARF will require 
further analysis. Coexpressed p161NK4” (Figure 4C, lanes 
3-7) was not detected with antiserum to plSARF, nor vice 
versa; neither did we ever observe N-terminally truncated 
P 1 6’NK4a polypeptides. arising by initiation from internal 
AUG codons within exon 2. When the cDNA encoding 
HA-tagged pl SARF was expressed under baculoviral con- 
trol in insect Sf9 cells, a protein of slightly slower mobility 
than that of the endogenous mouse protein was detected 
with antibody to p19 (Figure 48, lane 9) or to the HA tag 
(data not shown) but not with anti-p1 61NK4a (Figure 4C, lane 
9). As expected, /NK4a-negative NIH 3T3 cells failed to 
express endogenous p19 and ~16 (Figures 48 and 4C, 
lanes l), but their infection with a retrovirus containing 
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Figure 4. Expression of plSARF and ~16’~~~~ 
cDNAs encoding f116’~~~, plSARF, and HA-Tagged plSARF (indicated 
below [A]) were transcribed and translated in vitro. Proteins labeled 
with [YSjmethionine, normalized for equal input of radioactivity, were 
precipitated with nonimmune rabbit serum (NRS) or with antisera to 
C-terminal epitopes of ~16’~~~~ or plSARF (indicated at the top of the 
panel) and separated on denaturing gels. The positions of marker 
proteins of known molecular mass are indicated at the right. Lysates 
from cell lines indicated at the top of(B) included mouse NIH 3T3 and 
insect Sf9 cells infected with vectors encoding plSARF (plus ~19; lanes 
2 and 9). Mammalian cell lysates (lanes l-7; 800 ug of protein per 
ml) were taken for sequential immunoprecipitation and immunoblotting 
with antisera to plSARF (B) or to p16 INKJa (C). Sf9 lysates (lanes 8 and 
9; 2 x IO5 cell equivalents per lane) were electrophoresed directly. 
The positionsof plSAAF, HA-tagged ~19, p161NK4”, and immunoglobulin 
(lg) light chains (L) are indicated in the margins; no other bands apart 
from immunoglobulin heavy chains were detected on the blots. 
plSARF Can Induce Cell Cycle Arrest 
Infection of NIH 3T3 cells for 48 hr with retroviruses encod- 
ing plSARF induced cell cycle arrest in both the Gl (2N 
DNA content) and G2/M (4N DNA content) phases of the 
cell cycle, with a concomitant loss of cells in S phase (DNA 
content between 2N and 4N) (Table 1). Incorporation of 
BrdU into their cellular DNA 48 hr after infection was re- 
duced to - 10% of that seen in empty vector-infected 
cells, which remained distributed through the cycle. NIH 
3T3 cells engineered to overexpress cyclin Dl have a 
20%-300/o contracted Gl phase and a compensatory 
shortening of their doubling time, so that their overall cell 
cycle distribution is unchanged (Quelle et al., 1993). When 
infected with the plSARF vector, a greater proportion of 
cyclin Dl overexpressors arrested in G2/M versus Gl (Ta- 
ble l), suggesting that cyclin Dl may act to overcome the 
pl g-induced G 1 block partially. BALB 3T3 fibroblasts have 
a relatively high S phase fraction when continuously prolif- 
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Table 1. Cell Cycle Arrest by plQRF 
Cell Cycle Distribution 
Cell Line 
(48 hr Postinfection) 
(Number of Explants) Vector/cDNA Insert Percent GdGl Percent S Percent G21M 
NIH 3T3 (7) none 42.4 f 3.3 42.0 r 2.3 15.6 f 3.3 
NIH 3T3 (8) p1WF 66.6 -t 5.2 12.5 r 2.6 20.9 + 5.1 
3T3 Dl (8) none 41.1 * 6.8 39.1 * 4.4 19.8 f 2.7 
3T3 Di (9) p19ARF 53.0 f 4.3 11.6 + 2.8 35.4 k 4.2 
BALB 3T3 (3) none 36.5 f 8.9 49.0 f 8.8 14.5 * 1.2 
BALI3 3T3 (3) p1WF 57.1 f 4.9 26.0 f 2.8 16.9 f 1.4 
The DNA content of NIH 3T3 cells infected for 48 hr with a control vector or with retroviruses encoding plSARF was determined by fluorescence- 
activated cell sorting analysis. Proliferating polyclonal derivatives overexpressing cyclin Di (3T3 Dl) are not redistributed through the cell cycle, 
because the shortening of their Gl phase by 20%-30% is compensated by a reduced generation time (Quelle et al., 1993). pl9-induced G21M 
arrest in cyclin D overexpressors was more marked than in parental cells. Arrested cells were fully viable, lacked metaphases, and contained 
intact nuclei (Figure 5), indicative of arrest in interphase. 
erating, but Gl arrest predominated in those forced to 
express pl SARF. Therefore, pl9-induced arrest signifi- 
cantly decreased the fraction of fibroblasts in S phase 48 
hr postinfection, but the percentage accumulating in Gl 
or G2/M was not simply predicted by the initial distribution 
of cells throughout the cycle at the time of infection. 
The fact that plSARF can induce cell cycle arrest in NIH 
3T3 cells indicates that it can function independently of 
pl 61NK4a. In the case of BALB 3T3 cells that express endog- 
enous pl SARF, experiments with vectors encoding HA- 
tagged pl9 revealed that the ectopically synthesized pro- 
tein exceeded the amount of endogenous pl gnRF by only 
-2- to 3-fold, whereas in INK&-negative NIH 3T3 cells, 
much higher levels of p19 expression were routinely real- 
ized (c.f. Figure 4B, lane 2). Therefore, any differences 
in the response of these cells to plSARF might reflect the 
relative levels of ectopic pl9ARF expression, deletion of 
INK& from NIH 3T3 cells, defects in Gl and G2/M check- 
point controls that confer partial plSARF resistance, or a 
combination of these. 
Many plSARF-infected NIH 3T3 cells appeared small, 
rounded, and refractile, superficially similar to those in 
mitosis. However, they yielded only a minor (<0.2%) meta- 
phase fraction when compared with - 3% of cells infected 
with the vector control. Cells forced to express plSARF did 
not undergo apoptosis, as determined by a highly sensitive 
flow cytometric assay for DNA fragmentation (see Experi- 
mental Procedures). Cytospins were prepared from NIH 
3T3 cells 48 hr after infection with viruses encoding HA- 
tagged ~19, and immunofluorescence performed with an- 
tibodies to the p19 C-terminus (Figure 5A) or to the 
N-terminal HA epitope (Figure 5C) revealed the protein in 
the cell nucleus. More than 90% of infected NIH 3T3 cells 
stained brightly as compared with uninfected cells (data 
not shown) or those stained with peptide-blocked serum 
(Figure 5B). No nuclear dissolution or mitotic figures were 
observed, confirming that the positively stained cells ar- 
rested in interphase. In asynchronously proliferating BALB 
3T3 derivatives that express relatively high levels of en- 
dogenous pl SARF (see Figure 4B, lanes 3-5), we observed 
punctate p19 staining in the nuclei of all cells (Figure 5D). 
pl SARF was detected in S and non-S phase cells (compare 
figures 5D and 5E) and did not localize to BrdU-stained 
replication centers as determined by dual color staining 
(see Figure 5 legend). 
plSARF Is Not a Direct CDK Inhibitor 
When lysates of pl9-infected NIH 3T3 cells were precipi- 
tated with specific antisera to CDC2 or CDK2 and histone 
Hl kinase activity was measured in immune complexes, 
the activities of both CDKs in arrested cells were reduced 
relative to those in proliferating populations infected with 
the control vector (data not shown). An observed -5fold 
decrease in total CDCP kinase activity was consistent with 
loss of ceils in mitosis, whereas an - IO-fold drop in CDKP 
activity likely reflected the redistribution of cells from S 
phase into Gl and G2. Given the dissimilarity in structure 
between plSARF and known CDK inhibitors, it seemed 
highly unlikely that the protein would interact directly with 
CDKs or cyclins. In agreement, when CDC2, CDK2, CDKs 
4-6, cyclins D2, D3, E, and A immunoprecipitates from 
MEL cell lysates were blotted with anti-p1 SARF, no copreci- 
pitation of p19 was observed. Moreover, when active com- 
plexes of recombinant cyclin Dl-CDK4, cyclin E-CDK2, 
cyclin A-CDKP, and cyclin B-CDC2 assembled in insect 
Sf9 cells were incubated in vitro with Sf9 extracts con- 
taining recombinant plSARF, complexes recovered by pre- 
cipitation with specific antisera to CDKs or cyclins lacked 
associated pl pRF and remained fully enzymatically active 
(negative data not shown). Under the same conditions, 
holoenzyme complexes exposed to the universal CDK in- 
hibitor ~27~‘~’ bound the protein and were completely in- 
hibited. Therefore, the mechanism by which plSARF 
induces Gl and G2 phase arrest remains unclear, and its 
effects on CDK activity in vivo are likely to be indirect. 
Do plSARF Mutations Play a Role in Human Cancer? 
Current evidence indicates that p16jNK4” functions up- 
stream of cyclin D-dependent kinases and pRB in a bio- 
chemical pathway that regulates exit of Gl phase cells 
into S phase. p16 cannot induce Gl arrest in cells that 
lack pRB function (Guan et al., 1994; Tam et al., 1994; 
Lukas et al., 1995; Medemaet al., 1995; Koh et al., 1995), 
and in lung cancer, INK4a deletions are restricted to tu- 
mors that retain RB activity and vice versa, implying that 
a loss of either gene makes compromise of the other irrele- 






Figure 5. Nuclear Localization of plSARF 
Cytospin preparations of NIH 3T3 cells infected for 48 hr with a vector 
encoding HA-tagged pl SARF were fixed and stained with antiserum to 
pl9AffF (A), anti-plSAAF plus cognate peptide (B), or anti-HA serum 
(C). Uninfected NIH 3T3 cells yielded background signals less intense 
than those seen in (B). Matched exposures are shown at 575 x magnifi- 
cation. Expression of endogenous plSARF (D) in p53-negative BALB 
3T3 cells (clone 10-l) was also observed in intact nuclei by use of a 
Texas red streptavidin-biotin detection system. The same cells were 
labeled with BrdU for 60 min prior to fixation (E), and those in S phase 
(also labeled with arrows in ID]) were detected with an FITC monoclonal 
antibody (originally green). Foci of green and red punctate nuclear 
staining did not conspicuously overlap (yellow; data not shown). 
vant (Otterson et al., 1994). Increased levels of ~16’~~~~ 
are commonly observed in pRB-negative tumor Cells (Ser- 
rano et al., 1993; Bates et al., 1994; Lukas et al., 1994; 
Tam et al., 1994), suggesting that p16rNKti expression may 
be somehow governed by pRB itself or, alternatively, pro- 
vides a predisposing selective pressure that favors elimi- 
nation of pRB-mediated controls (Sherr and Roberts, 
1995).Ofthenumerouspl6 INK4a mutations found in human 
cancers, only few have been experimentally evaluated for 
effects on the cell cycle. However, two that abrogate pl6 
inhibitory functions (R87P and H98P, in Koh et al., 1995) 
are silent in plSARF, and another (P114L, in Lukas et al., 
1995) falls outside the region of overlap between pl6 and 
p19, indicating that the latter is not a target of inactivating 
mutations in these cases. Therefore, pl 6rNK4” likely acts 
as a bona fide tumor suppressor protein. 
Nevertheless, most mutations involving INK4a in cancer 
cells fall within the 5’ half of exon 2, raising the possibility 
that some may dually affect pl 6iNK4aand plSARFor, conceiv- 
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Figure 6. Predicted Mutations of plSARF in Cancers 
The majority of INK4a mutations so far described target the 5’ portion 
ofINK4aexon2(Hiramaand Koeffler, 1995) whichencodessegments 
of both ~16”‘~~ and p19*kF. Comparison of the mouse (upper) and 
human (lower) pl VF amino acid sequences defines conserved resi- 
dues (boldface type). Residues in the human gene that have sustained 
mutations in cancer cells are doubly underlined, and sequence alter- 
ations are indicated below them. Silent mutations in the pl 61NK’B coding 
frame predicted to affect only plSAAF primary structure are indicated 
by asterisks (e.g., P71T*). Superscripts note multiple substitutions of 
the same residue (e.g., G66L3 was independently observed in three 
cases), and closed squares define microdeletions plus frameshifts. 
No nonsense mutations were found. All mutations were detected in 
sporadic cancers except for R114L (GlOlW in PIG”‘@), which has 
been genetically implicated in familial melanoma in three of nine kin- 
dreds (Hussussian et al., 1994; Kamb et al., 1994b). Known sequence 
polymorphisms have been excluded. The remaining data were taken 
from the following references: Caldas et al. (1994) Hayashi et al. 
(1994) Kamb et al. (1994a), Mori et al. (1994) Ohta et al. (1994), and 
Zhang et al. (1994). Numbering of p16rNK” amino acid sequences in 
the text is based on the corrected N-terminus (Hannon and Beach, 
1994) which includes eight residues beyond those originally identified 
(Serrano et al., 1993). 
ably, p19 alone. It is unclear from many previous reports 
whether others may have dismissed wobble mutations in 
~16’~~~~ that might otherwise affect plSARF function. About 
60% of the reported amino acid mutations in p16 cluster 
within the region overlapping p19 (Hirama and Koeffler, 
1995), and more than 80% of these affect pl SARF primary 
structure. Figure 6 shows the predicted p19 mutations 
within this segment, compiled from data obtained with pri- 
mary tumors, xenografts, and established cell lines (Kam b 
et al., 1994a, 1994b; Caldas et al., 1994; Hussussian et 
al., 1994; Ohta et al., 1994; Zhang et al., 1994; Mori et al., 
1994; Hayashi et al., 1994). Of 50 missense and frameshift 
mutations, 39 involve residues conserved between human 
and mouse p19 (residues in boldface type), and four that 
are silent in pl6 (marked by asterisks) alter pl9 exclu- 
sively. The most frequently mutated pl9 residues in spo- 
radic cancers are Gly-68, Pro-93, and Arg-97, each of 
which is conserved in humans and mice, and the most 
common disease-related alteration in melanoma kindreds 
(Hussussian et al., 1994; Kamb et al., 1994b) converts 
conserved Arg-114 of p19 to leucine. A further complica- 
tion is that frameshift mutations have the potential to pro- 
duce chimeric proteins. For example, those involving p19 
Gln-69 (Hayashi et al., 1994) and Gly-72 (Ohta et al., 1994) 
should result in INK4a a transcripts encoding p16-~19 
fusions in which the majority of exon 2 sequences encode 
pl9 residues. Conversely, a p19 frameshift involving Gly- 
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101 (Hayashi et al., 1994) would yield a b transcript encod- 
ing the C-terminal half of ~16. The possibility that plQARF 
contributes to aberrant growth control and tumorigenesis 
therefore needs to be evaluated. 
There are precedents for dual utilization of coding se- 
quences in small virus genomes that cannot exceed a 
complexity that prevents their packaging into virions 
(Lamb and Horvath, 1991; Cullen, 1991). In contrast, eu- 
karyotic genes are composed largely of introns and are 
more widely spaced, presumably relieving them from evo- 
lutionarily imposed size constraints. In Saccharomyces 
cerevisiae, the SW6 locus and genes encoding certain 
glycolytic enzymes exhibit overlapping reading frames on 
opposite strands (Estruch and Carlson, 1990; Boles and 
Zimmermann, 1994), whereas the stress response gene 
DDR48 includes two overlapping frames, each with a ca- 
pacity to encode a protein of -45 kDa (Treger and 
McEntee, 1990). In these cases, however, only one of the 
two frames appears to be expressed. Recently, Labarribre 
et al. (1995) reported that transcripts originating from a 
novel promoter in the human growth hormone (G/-I) gene 
have, the potential to specify a 107 amino acid protein, 
the C-terminal half of which arises from a second reading 
frame in GH exons 1 and 2. Antibodies to the C-terminus 
of this predicted polypeptide histochemically stained a 
subpopulation of pituitary cells, arguing for limited focal 
translation of this mRNA. In general, overlapping genes 
noted as such in the available databases have not been 
assigned dual protein products. That two INK4a-coded 
polypeptides can each induce cell cycle arrest, albeit at 
different points in the cycle and via apparently distinct 
mechanisms, suggests that their unitary inheritance may 
underlie some functional interaction. 
Experimental Procedures 
Cells and Culture Conditions 
Mammalian cell lines were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM 
glutamine, and 100 U/ml penicillin and streptomycin (GIBCO, Grand 
Island, NY). NIH 3T3 cells (RB+, INK4a-, p53 status uncertain) were 
transfected with pRc/RSV-cyclin Di, and polyclonal populations de- 
rived from pooled, drug-resistant transformants were used where indi- 
cated (Quelle et al., 1993). BALE 3T3 cells (RB status uncertain, 
INK4a+, ~53 wild-type) and derivatives (clones 10-l and IO-3 null for 
p53 and p53-compromised cells stably expressing MDM2) were pro- 
vided by G. Zambetti (St. Jude Children’s Research Hospital). The 
293T retrovirus packaging line (Pear et al., 1993) was obtained from 
C. Sawyers (University of California, Los Angeles) with permission 
from D. Baltimore (Massachusetts Institute of Technology). 
cDNA Isolation and Plasmid Constructions 
A MEL cell cDNA library(5’Stretch IgtlO, Clontech, Palo Alto, CA) was 
screened with a full-length human ~16’~~~” probe, and 12 hybridizing 
cDNAs subcloned into pBluescript (Stratagene, La Jolla, CA) were 
sequenced. One cDNA represented mouse ~16’~~~ (Quelle et al., 
1995) while the remaining clones, designated plSARF, contained al- 
ternative sequences derived from exon 18. Sequences encoding a HA 
epitope tag were added to the 5’end of the plSARF cDNA by PCR using 
a forward primer containing a 5’ BamHl site (5’CGGGATCCGAATTC 
AGCCATGGGTTACCCATACGACGTCCCAGACTACGCTACCGGTC- 
GCAGGTTCTTGGTCAC3’) and a reverse primer extending over the 
single BssHll site in exon 16 (S-GCCCGCGCGCTGAATCCTCA-3’). 
The PCR product was digested with BamHl and BssHII, subcloned into 
the original cDNA in pBluescript, and resequenced. For expression in 
insect Sf9 cells (Kato et al., 1993) an EcoRl fragment encoding tagged 
pl SARF was inserted into the pVL1393 baculovirus vector (PharMingen, 
San Diego, CA). Both untagged and HA-tagged pl pRF cDNAs were 
subcloned into the EcoRl site of the SRa-MSV-tk-neo retroviral vector 
(Muller et al., 1994) for production of virus. 
Virus Production and Infections 
Human kidney 293T cells were transfected with 15 ng of ecotropic 
helper virus DNA plus 15 pg of SRa vector DNA by a modified calcium 
phosphate precipitation technique (Chen and Okayama, 1987). Cell 
supernatants containing infectious retroviral pseudotypes were har- 
vested 24-60 hr posttransfection, pooled on ice, and filter (0.45 pm)- 
sterilized. Virus infections of exponentially growing mouse fibroblasts 
in 100 mm diameter culture dishes were performed at 37% in a 5% 
CO* atmosphere with 2 ml of virus-containing supernatants containing 
8 nglml polybrene (Sigma, St. Louis, MO). After 3 hr, 10 ml of fresh 
medium was added. Cells were harvested 48 hr after infection, and 
their DNA content was analyzed by flow cytometry (Matsushime et 
al., 1991). Insect SfQ cells were infected and harvested as previously 
described (Kato et al., 1993). 
qrotein Analysis 
Coupled in vitro transcription and translation of mouse plSARF, HA- 
tagged pl QARF, and pl 6rNK4’ were carried out with 1 ng of supercoiled 
DNA templates for 90 min at 30% (TnT kit; Promega, Madison, WI). 
Products (5 pl) were immunoprecipitated for 2 hr at 4OC in cell lysis 
buffer (120 mM NaCI, 50 mM’Tris [pH 8.01, 0.5% NP-40) with protein 
A-Sepharose and rabbit polyclonal antisera (Rockland, Gilbertsville, 
PA) generated against synthetic, conjugated C-terminal peptides for 
plQARF (NH2-VFVYRWERRPDRRA) or p16rNKqa (Quelle et al., 1995). 
Immune complexes were washed four times in cell lysis buffer, boiled 
in gel loading buffer, and analyzed by electrophoresis on denaturing 
14% polyacrylamide gels containing sodium dodecyl sulfate (SDS). 
Slab gels impregnated with Amplify (Amersham, Arlington Heights, 
IL) were dried and exposed to X-ray film. 
For analysis of plQARF or p161NK4” expression, pelleted mammalian 
cells were disrupted in ice-cold cell lysis buffer by sonication 
(1 x 10’ cells/ml) and left for 1 hr on ice. Nuclei and debris were 
removed by centrifugation in a microfuge at 12,000 rpm for 10 min at 
4%. Proteins (adjusted to 800 Kg/ml) were immunoprecipitated and 
separated on denaturing gels as above and transferred onto nitrocellu- 
lose(Quelleetal., 1993). Proteinsweredetected byenhancedchemilu- 
minescence (ECL, Amersham) according to the specifications of the 
manufacturerwith pl~RForp161NK4a antiseraor with 12CA5 monoclonal 
antibody to the HA tag (ICN, Costa Mesa, CA). Assays for CDCP and 
CDK2-associated histone HI kinase activity were performed as pre- 
viously described (Matsushime et al., 1992). In some experiments, 
specifically immunoprecipitated CDKs or cyclins were separated on 
denaturing gels and immunoblotted with anti-plSARF as above. 
RT-PCR Analysis 
Polyadenylated mRNAwas prepared from tissues excised from normal 
female mice (C3H/HEJ, Jackson Laboratories, Bar Harbor, ME), and 
cDNA was synthesized from 50 ng of poly(A) mRNA templates ac- 
cording to the instructions of the manufacturer (StrataScript RT-PCR 
kit, Stratagene) (Quelle et al., 1995). PCR amplification of either mouse 
plQARF 5 transcripts (specific sense primer, S-AGGGATCCTTGGT- 
CACTGTGAGGATTC-3’) or mouse ~16”‘~~’ a transcripts (specific 
sense primer, 5’CGGGATCCGCTGCAGACAGACTGGCCAG-3’) was 
performed with a common antisense primer (5’-GCAAAGCTTGAGGC- 
CGGATTTAGCTCTGCTC-3) with 35 cycles of denaturation (95%, 
1 min), annealing (65% 45 s), and extension (72%, 2 min). Products 
(- 0.5 kb, 10 pl per lane) were electrophoresed on 1.5% agarose 
gels and blotted onto nylon membranes (Hybond N, Amersham). 
32P-labeled probes that specifically recognized exon 1 j3 (pl QARF, bases 
l-226) exon la (p16rNKQ, bases 56-162) or exon 2 (antisense oligo, 
5’-GCTCTAGAGCGTGTCCAGGAAGCCTTCC-3’) were hybridized at 
50% in neutral pH buffer containing 0.9 M NaCl and washed in 0.015 
M NaCI, 0.1% SDS at the same temperature. 
Apoptosis Assay 
Trypsinized cell suspensions were washed and suspended in 0.5 ml 
INK4a Alternative Reading Frame (ARF) Protein 
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of phosphate-buffered saline (PBS) and pipetted dropwise into 5 ml of 
1% buffered paraformaldehyde on ice with gentle mechanical mixing. 
After a 15 min incubation on ice, cells were pelleted and washed with 
10 ml of cold PBS, and the pellets were resuspended in 1 ml of 70% 
ethanol precooled to -2OOC. Samples stored at -20°C overnight were 
resuspended, divided into two equal aliquots, collected by centrifuga- 
tion, and washed twice with ice-cold PBS. Duplicate samples were 
resuspended in 50 ul of reaction mixtures containing 1 x terminal 
deoxynucleotidyl transferase (TdT) buffer, CoCI,, and digoxigenin-1 f- 
UTPwithorwithout0.5~lofTdT(alIsuppliedasaTdTkitbyBoehringer 
Mannheim). After a 30 min incubation at 37OC, 1 ml of ice-cold PBS 
was added, and recentrifuged cells were suspended in 100 ul of a 1:40 
dilution in PBS of anti-digoxigenin-fluorescein isothiocyanate (FITC) 
monoclonal antibody and incubated for 30 min in the dark at room 
temperature. Cells were sequentially washed in 1 ml of ice-cold PBS 
containing 2 mM sodium azide and 0.35% bovine serum albumin 
(BSA), and then in 1 ml of 0.1% Triton X-100 in PBS, and resuspended 
in 1 ml of PBS-azide-BSA containing 50 uglml propidium iodide. 
RNase (50 9glml) was added, and after a 30 min incubation at room 
temperature, samples were filtered for flow cytometry and analyzed 
for DNA content (red PI fluorescence) and TdT-labeled DNA fragments 
(green FITC) on a Becton Dickinson FACScan (Matsushime et al., 
1991). DNA fragmentation was quantitated by determining the differ- 
ence in FITC fluorescence between duplicate samples incubated with 
and without TdT. Human Jurkat T cells treated with 100 uM etoposide 
for 6 hr were routinely included as positive controls for cells undergoing 
apoptosis. 
lmmunofluorescence 
Cells were harvested 48 hr after infection and spun onto glass slides 
(5 x lo4 cells/slide) with a Scimetrics Cytospin 3 at 500 rpm for 5 min. 
Following fixation for IO min at room temperature in 3% paraformalde- 
hyde, slides were washed three times with PBS, permeabilized in 0.2% 
Triton X-100 for 10 min at room temperature, and washed three more 
times with PBS. After a 30 min incubation in blocking solution (PBS 
containing 1% dry milk), cells were incubated at room temperature in 
a humidified chamber for 1 hr with primary antibody (5 uglml 12CA5 
MAb or 1:600 plSARF polyclonal antiserum diluted in blocking solution). 
After six washes with blocking solution, secondary antibody incuba- 
tions were performed in blocking solution for 30 min, with 1:50 dilutions 
of either FITC-conjugated sheep anti-mouse or FITC-conjugated don- 
key anti-rabbit immunoglobulin G (Amersham). After six washes with 
PBS, cells were stained with Hoechst dye 33258 (1 ug/ml), wet- 
mounted with Vectashield medium (Vector, Burlingame, CA), and pho- 
tographed at 600 x magnification through a microscope equipped with 
epifluorescenceoptics(Olympus, Lake Success, NY). With cellsgrown 
on glass coverslips, costaining of p19 ARF (1:50 dilution of affinity- 
purified polyclonal antiserum) and BrdU (undiluted monoclonal anti- 
body plus nuclease, Amersham) was performed exactly as described 
by Pagan0 et al. (1994). 
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